Potential of machine learning to predict early ischemic events after carotid endarterectomy or stenting: A comparison with surgeon predictions - Matsuo, Kazuya; Fujita, Atsushi; Hosoda, Kohkichi; Tanaka, Jun; Imahori, Taichiro; Ishii, Taiji; Kohta, Masaaki; Tanaka, Kazuhiro; Uozumi, Yoichi; Kimura, Hidehito; Sasayama, Takashi; Kohmura, Eiji (medRxiv, 2021)
Background Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are recommended for high stroke-risk patients with carotid artery stenosis to reduce ischemic events. However, we often face difficulty in determining the best treatment strategy.Objective We aimed to develop an accurate post-CEA/CAS outcome prediction model using machine learning that will serve as a basis for a new decision support tool for patient-specific treatment planning.Methods Retrospectively collected data from 165 consecutive patients with carotid stenosis underwent CEA or CAS were divided into training and test samples. The following five machine learning algorithms were tuned, and their predictive performance evaluated by comparison with surgeon predictions: an artificial neural network, logistic regression, support vector machine, random forest, and extreme gradient boosting (XGBoost). Seventeen clinical factors were introduced into the models. Outcome was defined as any ischemic stroke within 30 days after treatment including asymptomatic diffusion-weighted imaging abnormalities.Results The XGBoost model performed the best in the evaluation; its sensitivity, specificity, positive predictive value, and accuracy were 31.9%, 94.6%, 47.2%, and 86.2%, respectively. These statistical measures were comparable to those of surgeons. Internal carotid artery peak systolic velocity, low density lipoprotein cholesterol, and procedure (CEA or CAS) were the most contributing factors according to the XGBoost algorithm.Conclusion We were able to develop a post-procedural outcome prediction model comparable to surgeons in performance. The accurate outcome prediction model will make it possible to make a more appropriate patient-specific selection of CEA or CAS for the treatment of carotid artery stenosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially supported by research funds from the Alumni Association of the Department of Neurosurgery, Kobe University School of Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethical Committee of Kobe University Graduate School of Medicine (approval no. B200444).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe patient data that support the findings of this study are available from the corresponding author upon reasonable request. A subset of the program code generated for this study is available at GitHub. https://gist.github.com/kkmatsuo/e77e78a0346280d5570829164760132f